2024-11-14 NaaS Technology Inc. HaiPress
BEIJING,Nov. 13,2024 --NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"),the first U.S.-listed EV charging service company in China,today announced that it will report its unaudited financial results for the third quarter ended September 30,2024 before the U.S. market opens on Wednesday,November 20,2024.
The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern time on November 20,2024 (9:00 PM Beijing/Hong Kong time on November 20,2024).
For participants who wish to join the conference using dial-in numbers,please complete online registration using the link provided below prior to the scheduled call start time.
Participant Online Registration:
https://dpregister.com/sreg/10194471/fdf6d1042c
Upon registration,each participant will receive details for the conference call,including dial-in numbers,passcode and a unique access PIN. To join the conference,please dial the provided number,enter the passcode followed by your PIN,and you will join the conference.
Additionally,a live and archived webcast of the conference call will be available on the Company's investor relations website at http://ir.enaas.com.
A replay of the conference call will be accessible approximately one hour after the conclusion of the live call until November27,2024,by dialing the following telephone numbers:
US (Toll Free):
+1-877-344-7529
International:
+1-412-317-0088
Replay Passcode:
6398178
About NaaS Technology Inc.
NaaS Technology Inc. is the first U.S. listed EV charging service company in China. The Company is a subsidiary of Newlinks Technology Limited,a leading energy digitalization group in China. The Company provides one-stop solutions to energy asset owners comprising charging services,energy solutions and new initiatives,supporting every stage of energy assets' lifecycle and facilitating energy transition.
For investor and media inquiries,please contact:
Investor Relations
NaaS Technology Inc.
E-mail:ir@enaas.com
Media inquiries:
E-mail:pr@enaas.com
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Diet Tips Daily